Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, announced that Randall ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

University of Delaware's Mona Batish is a molecular biologist. She studies circular RNAs formed as a result of so-called ...

Concern is growing among public health experts that anti-vaccine sentiment within federal and state governments may derail ...

For the first time, researchers have revealed the high-affinity interaction between mitochondrial proteins HAX1 ...

State legislators are moving to advance US Health and Human Services Secretary Robert F. Kennedy Jr.’s push for greater ...

The team created a novel tick antigen library housing over 3,000 different proteins, testing each to create a target cocktail ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

For the first time since Robert F. Kennedy Jr. became health secretary, vaccine advisers to the CDC are meeting to discuss vaccines for RSV, HPV, COVID and more.